Russell Investments Group Ltd. Raises Position in Oscar Health, Inc. (NYSE:OSCR)

Russell Investments Group Ltd. grew its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 63.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 216,782 shares of the company's stock after purchasing an additional 84,029 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.09% of Oscar Health worth $2,914,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. KBC Group NV raised its holdings in Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after purchasing an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in Oscar Health during the 4th quarter worth $100,000. Alberta Investment Management Corp purchased a new stake in Oscar Health in the fourth quarter valued at $138,000. Virtu Financial LLC acquired a new position in Oscar Health in the fourth quarter valued at $140,000. Finally, Potentia Wealth purchased a new position in shares of Oscar Health during the fourth quarter worth about $141,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

NYSE OSCR traded up $0.84 during trading on Wednesday, reaching $12.44. The company's stock had a trading volume of 751,421 shares, compared to its average volume of 4,501,419. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.79. The firm has a market cap of $3.12 billion, a price-to-earnings ratio of -621.69 and a beta of 1.75. The business's fifty day moving average price is $13.69 and its 200-day moving average price is $14.95. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their target price for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $20.21.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.